2020 American Transplant Congress

Saturday, May 30, 2020

3:39pm-3:51pm

Roles of Calpastatin in Ischemia/Reperfusion Injury in Aged Livers

J. Kim, C. Lee, W. Chapman

Basic: Ischemia Reperfusion & Organ Rehabilitation II  •  Virtual

3:39pm-3:51pm

Safety and Patency of Inferior Vena Cava Reconstruction with Artificial or Autologous Blood Vessels During Liver Autotransplantation: Five-Year Results from a Prospective Cohort Study of 73 Cases

T. Wang, X. Yang, W. Wang

Liver: Hepatobiliary Surgery and Liver Transplant Potpourri  •  Virtual

3:39pm-3:51pm

Single-Cell RNA Sequencing to Assess the Effect of IL-6 Receptor Blockade in Kidney Transplantation

A. Zarinsefat, P. Rashmi, A. Da Silva, T. Sigdel, S. Chandran, Q. Tang, J. Ye, F. Vincenti, M. Sarwal

Basic: Acute Rejection  •  Virtual

3:39pm-3:51pm

Sirolimus Plus Tacrolimus Immunosuppression, with or without Mycophenolate Mofetil, May Improve Survival after Bronchiolitis Obliterans Syndrome in Lung Transplant Patients

M. Wijesinha, M. Terrin, B. Griffith, A. Iacono

Living in the Real World: Decision Making and Outcomes After Lung Transplant  •  Virtual

3:39pm-3:51pm

Survey of Clinician Opinions on Use of Organ Transplants from Hepatitis C Virus Positive Donors: Identifying & Overcoming Barriers

K. Lentine¹, T. Alhamad², D. Peipert³, Y. Caliskan¹, B. Concepcion⁴, R. Forbes⁴, M. Schnitzler¹, Z. Zhang¹, S. Chang², M. Cooper⁵, R. Bloom⁶, R. Mannon⁷, D. Axelrod⁸

All Organs: Viral Hepatitis  •  Virtual

3:39pm-3:51pm

Testing Deceased Organ Donors for Infections: An Organ Procurement Organization (OPO) Survey

N. M. Theodoropoulos¹, P. Chin-Hong², M. Greenwald³, M. G. Ison⁴

Donor Derived Infections  •  Virtual

3:39pm-3:51pm

The Economic Impact of National Standardization of Virtual Crossmatch Usage in Kidney Transplantation

J. E. Stanton¹, L. M. Rebellato², H. Pournik¹, J. E. Tuttle-Newhall¹, H. Jones¹, W. Irish¹, D. B. Leeser¹

All Organs: Economics & Ethics  •  Virtual

3:39pm-3:51pm

The Impact of DSA Screening in Stable Kidney Transplant Recipients in the 1st Year Post-Transplant

A. Sharma¹, D. Jorgensen², R. Mehta¹, P. Sood¹, C. Wu¹, C. M. Puttarajappa¹, A. Tevar¹, S. Hariharan¹

Biomarkers, Immune Assessment and Clinical Outcomes VI  •  Virtual

3:39pm-3:51pm

Three-Month Results of a Phase 2 Trial Evaluating Clazakizumab in Late Antibody-Mediated Rejection – Early Impact of Interleukin-6 Blockade on Donor-Specific Antibody Levels, Rejection Morphology and Gene Expression

G. A. Böhmig¹, M. Dürr², B. Jilma³, F. Eskandary¹, E. Chong⁴, S. Schranz³, K. Doberer¹, M. Wahrmann¹, A. Borski¹, H. Regele⁵, J. Kläger⁵, R. Reindl-Schwaighofer¹, J. Reeve⁶, K. Budde², P. F. Halloran⁶

Kidney Chronic Antibody Mediated Rejection  •  Virtual

3:39pm-3:51pm

Tonic-Signaling Chimeric Antigen Receptors Drive Exhaustion in Regulatory T Cells

C. Lamarche¹, C. Mackall², E. Weber³, M. Levings⁴

Cellular Therapies, Tissue Engineering / Regenerative Medicine  •  Virtual